全身免疫炎症指数与急性ST段抬高型心肌梗死PCI术后无复流相关性研究  

Correlation of systemic immune-inflammatory index with no-reflow after PCI for acute ST-segment elevation myocardial infarction

作　　者：黄军[1] 廖红英[1] 付幼林 黄庆 罗刚[1] Huang Jun;Liao Hongying;Fu Youlin;Huang Qing;Luo Gang(Ganzhou People’s Hospital,Ganzhou,Jiangxi 341000,China)

机构地区：[1]江西省赣州市人民医院,江西赣州341000

出　　处：《首都食品与医药》2025年第8期45-47,共3页Capital Food Medicine

基　　金：江西省卫生健康委科技计划项目(编号:202311970)。

摘　　要：目的探讨全身免疫炎症指数与急性ST段抬高型心肌梗死PCI术后无复流的相关性。方法回顾性分析2023年1月-2024年10月我院收治的180例行PCI治疗的急性ST段抬高型心肌梗死(STEMI)患者临床资料,依据术后有无复流分为无复流组(41例)与正常复流组(139例)。所有患者术前均采血并计算SII,收集患者年龄、性别、合并症、病变血管支数、病变部位、左心射血分数(LVEF)、三酰甘油(TG)、总胆固醇(TC)、空腹血糖(FPG)、SII等多方面基础资料进行对比;并绘制ROC曲线分析SII预测STEMI患者PCI术后无复流的临床价值。结果两组性别、年龄等一般资料相比,无明显差异(P>0.05);无复流组SII高于正常复流组,有统计学差异(P<0.05);绘制ROC曲线显示,SII预测PCI术后无复流的曲线下面积为0.978,临床价值高。结论SII在预测STEMI患者PCI术后无复流的价值高,便于早期识别高风险群体,以更好地完善治疗方案,确保PCI效果。Objective To investigate the correlation between systemic immuno-inflammatory index and no-reflow after PCI for acute ST-segment elevation myocardial infarction.Methods We retrospectively analyzed the clinical data of 180 patients with acute STsegment elevation myocardial infarction(STEMI)who underwent PCI from January 2023 to October 2024,and divided them into a noreflow group(41 cases)and a normal-reflow group(139 cases)based on the presence or absence of postoperative recurrent flow.Blood was collected from all patients before surgery and SII was calculated,and basic data such as age,gender,comorbidities,number of diseased vessels,lesion site,left heart ejection fraction(LVEF),triacylglycerol(TG),total cholesterol(TC),fasting blood glucose(FPG),SII and other basic data were collected for comparison;ROC curves were plotted to analyze the clinical value of SII in predicting the absence of regurgitation in patients undergoing PCI for STEMI.The clinical value of SII was analyzed.Results There was no significant difference between the two groups in terms of gender,age and other general information(P>0.05);the SII of the no-reflow group was higher than that of the normal-reflow group,with a statistically significant difference(P<0.05);and the drawing of the ROC curve showed that the area under the curve of the SII in predicting no-reflow after PCI was 0.978,which was of high clinical value.Conclusion SII has high value in predicting no-reflow after PCI in STEMI patients,which facilitates the early identification of high-risk groups,better improves the treatment plan,and ensures the effect of PCI.

关 键 词：急性心肌梗死 全身免疫炎症指数 经皮冠状动脉介入治疗 术后无复流 相关性 

分 类 号：R542.22[医药卫生—心血管疾病]